Along with the Q3 FY25 results, the state-owned company might also announce monetary rewards for its shareholders as a second interim dividend for FY25. In a regulatory filing earlier on January 15, ...
India's Dr Lal Path Labs reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3% higher.